GSN and familial dilated cardiomyopathy: Moreover, in human samples from DCM hearts, gelsolin activity is correlated with severity of myocardial dysfunction corroborating an important role gelsolin plays in the progression of DCM; therefore, pharmacological inhibition of gelsolin is a promising therapeutic approach to prevent adverse cytoskeletal remodeling in DCM.